NCT04981925

Brief Summary

The overall objective of this study is to better understand how Mindfulness-based Stress Reduction (MBSR) is the most helpful in terms of management of chronic pain symptoms. The studies hypothesis is that an Interventional Response Phenotyping study (light phenotyping) can identify individuals with different underlying mechanisms for their pain who thus respond differentially to evidence-based interventions for chronic pain disorders.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
381

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Aug 2021

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

July 19, 2021

Completed
10 days until next milestone

First Posted

Study publicly available on registry

July 29, 2021

Completed
3 days until next milestone

Study Start

First participant enrolled

August 1, 2021

Completed
3.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 30, 2025

Completed
28 days until next milestone

Study Completion

Last participant's last visit for all outcomes

February 27, 2025

Completed
Last Updated

August 24, 2025

Status Verified

August 1, 2025

Enrollment Period

3.5 years

First QC Date

July 19, 2021

Last Update Submit

August 18, 2025

Conditions

Keywords

chronic painrheumatoid arthritisfibromyalgianeuropathyneuralgiapain

Outcome Measures

Primary Outcomes (1)

  • PROMIS physical function 6b

    Physical Function 6b questionnaire will assess self-reported capability with 6 qualitatively scaled questions ranked on a 5-point scale, from "without any difficulty" to "unable to do" or "not at all" to "cannot do." The minimum raw summed score is 6 and the maximum score is 30. Lower scores suggest better outcomes.

    8 weeks (after MSBR)

Secondary Outcomes (5)

  • Change in PROMIS pain intensity, anxiety, pain interference

    Baseline (pre-treatment), 8 weeks

  • Change in PROMIS pain intensity, anxiety, pain interference

    Baseline (pre-treatment), 8 and 12 weeks

  • Change in Pain Catastrophizing Scale (PCS)

    Baseline (pre-treatment), 8 and 12 weeks

  • Pain Catastrophizing Score; measured with Pain Catastrophizing Scale

    8 weeks (after MSBR)

  • Change in Chronic Pain Acceptance Questionnaire (CPAQ)-8

    Baseline, 8 weeks (after MSBR)

Study Arms (1)

MBSR treatment

EXPERIMENTAL
Behavioral: MBSR treatment

Interventions

MBSR treatmentBEHAVIORAL

Participants will complete pre-treatment surveys followed by 8-weekly 2-hour group sessions and one 4-hour "retreat" (may take place virtually or in-person). Participants will also be asked to practice daily formal mindfulness at home using assigned audio recordings of 30-45 minute guided mindfulness exercises. Participants will complete surveys during treatment as well as after treatment and then at 2 months follow-up.

MBSR treatment

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Ages 18+
  • Any form of self-reported chronic pain (except cancer related pain)

You may not qualify if:

  • Unable to speak and write English
  • Visual or hearing difficulties that would preclude participation
  • Chronic pain from cancer.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Michigan

Ann Arbor, Michigan, 48109, United States

Location

MeSH Terms

Conditions

Chronic PainArthritis, RheumatoidFibromyalgiaNeuralgiaPain

Condition Hierarchy (Ancestors)

Neurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and SymptomsArthritisJoint DiseasesMusculoskeletal DiseasesRheumatic DiseasesConnective Tissue DiseasesSkin and Connective Tissue DiseasesAutoimmune DiseasesImmune System DiseasesMuscular DiseasesNeuromuscular DiseasesNervous System DiseasesPeripheral Nervous System Diseases

Study Officials

  • Todd Favorite, Ph.D.

    University of Michigan

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
BASIC SCIENCE
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Director, Psychological Clinic, Clinical Associate Professor of Mary A Rackham Institute, Graduate School and Associate Professor of Psychiatry

Study Record Dates

First Submitted

July 19, 2021

First Posted

July 29, 2021

Study Start

August 1, 2021

Primary Completion

January 30, 2025

Study Completion

February 27, 2025

Last Updated

August 24, 2025

Record last verified: 2025-08

Data Sharing

IPD Sharing
Will not share

Locations